Indian Firmís iPhone App Under FDA Scanner

by Kathy Jones on  May 27, 2013 at 6:47 PM News on IT in Healthcare   - G J E 4
A Mumbai-based medical technology firm has been asked by the US Food and Drug Administration to explain why it had not taken approval from the agency prior to releasing an app through which users can analyze their urine samples from their smartphones.
 Indian Firmís iPhone App Under FDA Scanner
Indian Firmís iPhone App Under FDA Scanner

The firm, Biosense, had developed an app known as uChek for iPhone through which smartphone users can analyze snapshots of their urine samples to detect a number of diseases, including diabetes, urinary tract infection and hepatitis.

However the FDA has sent a notice asking that as the app converted the user's phone into an automated strip reader, why did not the company seek FDA's approval before its release.

Biosense acknowledged that they have been contacted by the FDA and its co-founder, Myshkin Ingawale said that his company will be working close with the health regulatory body to ensure that they provide an accurate diagnostic tool. "We are in communication with the FDA as per their latest letter, and will be working closely with them over the coming months to ensure that we continue to deliver accurate, affordable and convenient diagnostics across the world", he said.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like